Urolithin B is a new bioactive compound, which is a linoleic acid compound produced by intestinal flora metabolism. Urolithin B has strong antioxidant capacity, can delay aging, improve health, and can effectively regulate physiological functions in the human body, protect cardiovascular health, and reduce the possibility of tumor occurrence.
The global Urolithin B market was valued at US$ 24.9 million in 2023 and is anticipated to reach US$ 37.2 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
North American market for Urolithin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urolithin B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urolithin B include Suzhou Myland Pharm & Nutrition Inc., Carlo Sessa SpA, Shandong Longilat Biotechnology Co., Ltd, Cofttek, BINBO BIOLOGICAL CO.,LTD, Xi'an Jincuifang Plant Technology Development Co., Ltd., Nanjing Bencao Yikang Biotechnology Co., Ltd., Hubei Wanzhi Chemical Pharmaceutical Co., Ltd., Zhejiang Hengtengfu Pharmaceutical Co., Ltd., Xi'an Tianguangyuan Biotechnology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urolithin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urolithin B.
The Urolithin B market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urolithin B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urolithin B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Suzhou Myland Pharm & Nutrition Inc.
Carlo Sessa SpA
Shandong Longilat Biotechnology Co., Ltd
Cofttek
BINBO BIOLOGICAL CO.,LTD
Xi'an Jincuifang Plant Technology Development Co., Ltd.
Nanjing Bencao Yikang Biotechnology Co., Ltd.
Hubei Wanzhi Chemical Pharmaceutical Co., Ltd.
Zhejiang Hengtengfu Pharmaceutical Co., Ltd.
Xi'an Tianguangyuan Biotechnology Co., Ltd.
Wuhan Dongkangyuan Technology Co., Ltd.
Sichuan Wekeqi Biotechnology Co., Ltd.
by Type
Purity: >98%
Purity: >99%
Others
by Application
Food Additives
Cosmetics
Drugs and Supplements
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urolithin B manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Urolithin B by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Urolithin B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Urolithin B 麻豆原创 Overview
1.1 Product Definition
1.2 Urolithin B by Type
1.2.1 Global Urolithin B 麻豆原创 Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Purity: >98%
1.2.3 Purity: >99%
1.2.4 Others
1.3 Urolithin B by Application
1.3.1 Global Urolithin B 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food Additives
1.3.3 Cosmetics
1.3.4 Drugs and Supplements
1.3.5 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Urolithin B Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Urolithin B Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Urolithin B Production Estimates and Forecasts (2019-2030)
1.4.4 Global Urolithin B 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Urolithin B Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Urolithin B Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Urolithin B, Industry Ranking, 2022 VS 2023
2.4 Global Urolithin B 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Urolithin B Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Urolithin B, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Urolithin B, Product Offered and Application
2.8 Global Key Manufacturers of Urolithin B, Date of Enter into This Industry
2.9 Urolithin B 麻豆原创 Competitive Situation and Trends
2.9.1 Urolithin B 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Urolithin B Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Urolithin B Production by Region
3.1 Global Urolithin B Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Urolithin B Production Value by Region (2019-2030)
3.2.1 Global Urolithin B Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Urolithin B by Region (2025-2030)
3.3 Global Urolithin B Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Urolithin B Production by Region (2019-2030)
3.4.1 Global Urolithin B Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Urolithin B by Region (2025-2030)
3.5 Global Urolithin B 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Urolithin B Production and Value, Year-over-Year Growth
3.6.1 North America Urolithin B Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Urolithin B Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Urolithin B Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Urolithin B Production Value Estimates and Forecasts (2019-2030)
4 Urolithin B Consumption by Region
4.1 Global Urolithin B Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Urolithin B Consumption by Region (2019-2030)
4.2.1 Global Urolithin B Consumption by Region (2019-2030)
4.2.2 Global Urolithin B Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Urolithin B Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Urolithin B Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Urolithin B Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Urolithin B Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Urolithin B Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Urolithin B Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Urolithin B Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Urolithin B Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Urolithin B Production by Type (2019-2030)
5.1.1 Global Urolithin B Production by Type (2019-2024)
5.1.2 Global Urolithin B Production by Type (2025-2030)
5.1.3 Global Urolithin B Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Urolithin B Production Value by Type (2019-2030)
5.2.1 Global Urolithin B Production Value by Type (2019-2024)
5.2.2 Global Urolithin B Production Value by Type (2025-2030)
5.2.3 Global Urolithin B Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Urolithin B Price by Type (2019-2030)
6 Segment by Application
6.1 Global Urolithin B Production by Application (2019-2030)
6.1.1 Global Urolithin B Production by Application (2019-2024)
6.1.2 Global Urolithin B Production by Application (2025-2030)
6.1.3 Global Urolithin B Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Urolithin B Production Value by Application (2019-2030)
6.2.1 Global Urolithin B Production Value by Application (2019-2024)
6.2.2 Global Urolithin B Production Value by Application (2025-2030)
6.2.3 Global Urolithin B Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Urolithin B Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Suzhou Myland Pharm & Nutrition Inc.
7.1.1 Suzhou Myland Pharm & Nutrition Inc. Urolithin B Company Information
7.1.2 Suzhou Myland Pharm & Nutrition Inc. Urolithin B Product Portfolio
7.1.3 Suzhou Myland Pharm & Nutrition Inc. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Suzhou Myland Pharm & Nutrition Inc. Main Business and 麻豆原创s Served
7.1.5 Suzhou Myland Pharm & Nutrition Inc. Recent Developments/Updates
7.2 Carlo Sessa SpA
7.2.1 Carlo Sessa SpA Urolithin B Company Information
7.2.2 Carlo Sessa SpA Urolithin B Product Portfolio
7.2.3 Carlo Sessa SpA Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Carlo Sessa SpA Main Business and 麻豆原创s Served
7.2.5 Carlo Sessa SpA Recent Developments/Updates
7.3 Shandong Longilat Biotechnology Co., Ltd
7.3.1 Shandong Longilat Biotechnology Co., Ltd Urolithin B Company Information
7.3.2 Shandong Longilat Biotechnology Co., Ltd Urolithin B Product Portfolio
7.3.3 Shandong Longilat Biotechnology Co., Ltd Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Shandong Longilat Biotechnology Co., Ltd Main Business and 麻豆原创s Served
7.3.5 Shandong Longilat Biotechnology Co., Ltd Recent Developments/Updates
7.4 Cofttek
7.4.1 Cofttek Urolithin B Company Information
7.4.2 Cofttek Urolithin B Product Portfolio
7.4.3 Cofttek Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Cofttek Main Business and 麻豆原创s Served
7.4.5 Cofttek Recent Developments/Updates
7.5 BINBO BIOLOGICAL CO.,LTD
7.5.1 BINBO BIOLOGICAL CO.,LTD Urolithin B Company Information
7.5.2 BINBO BIOLOGICAL CO.,LTD Urolithin B Product Portfolio
7.5.3 BINBO BIOLOGICAL CO.,LTD Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.5.4 BINBO BIOLOGICAL CO.,LTD Main Business and 麻豆原创s Served
7.5.5 BINBO BIOLOGICAL CO.,LTD Recent Developments/Updates
7.6 Xi'an Jincuifang Plant Technology Development Co., Ltd.
7.6.1 Xi'an Jincuifang Plant Technology Development Co., Ltd. Urolithin B Company Information
7.6.2 Xi'an Jincuifang Plant Technology Development Co., Ltd. Urolithin B Product Portfolio
7.6.3 Xi'an Jincuifang Plant Technology Development Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Xi'an Jincuifang Plant Technology Development Co., Ltd. Main Business and 麻豆原创s Served
7.6.5 Xi'an Jincuifang Plant Technology Development Co., Ltd. Recent Developments/Updates
7.7 Nanjing Bencao Yikang Biotechnology Co., Ltd.
7.7.1 Nanjing Bencao Yikang Biotechnology Co., Ltd. Urolithin B Company Information
7.7.2 Nanjing Bencao Yikang Biotechnology Co., Ltd. Urolithin B Product Portfolio
7.7.3 Nanjing Bencao Yikang Biotechnology Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Nanjing Bencao Yikang Biotechnology Co., Ltd. Main Business and 麻豆原创s Served
7.7.5 Nanjing Bencao Yikang Biotechnology Co., Ltd. Recent Developments/Updates
7.8 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd.
7.8.1 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd. Urolithin B Company Information
7.8.2 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd. Urolithin B Product Portfolio
7.8.3 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd. Main Business and 麻豆原创s Served
7.8.5 Hubei Wanzhi Chemical Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9 Zhejiang Hengtengfu Pharmaceutical Co., Ltd.
7.9.1 Zhejiang Hengtengfu Pharmaceutical Co., Ltd. Urolithin B Company Information
7.9.2 Zhejiang Hengtengfu Pharmaceutical Co., Ltd. Urolithin B Product Portfolio
7.9.3 Zhejiang Hengtengfu Pharmaceutical Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Hengtengfu Pharmaceutical Co., Ltd. Main Business and 麻豆原创s Served
7.9.5 Zhejiang Hengtengfu Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10 Xi'an Tianguangyuan Biotechnology Co., Ltd.
7.10.1 Xi'an Tianguangyuan Biotechnology Co., Ltd. Urolithin B Company Information
7.10.2 Xi'an Tianguangyuan Biotechnology Co., Ltd. Urolithin B Product Portfolio
7.10.3 Xi'an Tianguangyuan Biotechnology Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Xi'an Tianguangyuan Biotechnology Co., Ltd. Main Business and 麻豆原创s Served
7.10.5 Xi'an Tianguangyuan Biotechnology Co., Ltd. Recent Developments/Updates
7.11 Wuhan Dongkangyuan Technology Co., Ltd.
7.11.1 Wuhan Dongkangyuan Technology Co., Ltd. Urolithin B Company Information
7.11.2 Wuhan Dongkangyuan Technology Co., Ltd. Urolithin B Product Portfolio
7.11.3 Wuhan Dongkangyuan Technology Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Wuhan Dongkangyuan Technology Co., Ltd. Main Business and 麻豆原创s Served
7.11.5 Wuhan Dongkangyuan Technology Co., Ltd. Recent Developments/Updates
7.12 Sichuan Wekeqi Biotechnology Co., Ltd.
7.12.1 Sichuan Wekeqi Biotechnology Co., Ltd. Urolithin B Company Information
7.12.2 Sichuan Wekeqi Biotechnology Co., Ltd. Urolithin B Product Portfolio
7.12.3 Sichuan Wekeqi Biotechnology Co., Ltd. Urolithin B Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Sichuan Wekeqi Biotechnology Co., Ltd. Main Business and 麻豆原创s Served
7.12.5 Sichuan Wekeqi Biotechnology Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Urolithin B Industry Chain Analysis
8.2 Urolithin B Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Urolithin B Production Mode & Process
8.4 Urolithin B Sales and 麻豆原创ing
8.4.1 Urolithin B Sales Channels
8.4.2 Urolithin B Distributors
8.5 Urolithin B Customers
9 Urolithin B 麻豆原创 Dynamics
9.1 Urolithin B Industry Trends
9.2 Urolithin B 麻豆原创 Drivers
9.3 Urolithin B 麻豆原创 Challenges
9.4 Urolithin B 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Suzhou Myland Pharm & Nutrition Inc.
Carlo Sessa SpA
Shandong Longilat Biotechnology Co., Ltd
Cofttek
BINBO BIOLOGICAL CO.,LTD
Xi'an Jincuifang Plant Technology Development Co., Ltd.
Nanjing Bencao Yikang Biotechnology Co., Ltd.
Hubei Wanzhi Chemical Pharmaceutical Co., Ltd.
Zhejiang Hengtengfu Pharmaceutical Co., Ltd.
Xi'an Tianguangyuan Biotechnology Co., Ltd.
Wuhan Dongkangyuan Technology Co., Ltd.
Sichuan Wekeqi Biotechnology Co., Ltd.
听
听
*If Applicable.
